QUEENSBURY, N.Y.--(BUSINESS WIRE)--March 13, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release fiscal 2006 third quarter results after the market closes on Tuesday, March 21, 2006. Eamonn P. Hobbs, president and chief executive officer, and Joseph G.

Product Opens New Sales Opportunity; Designed for High-Flow Rate Injections for Radiology Imaging and Interventions FREMONT, Calif. and MANCHESTER, Ga., Feb. 28 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly traded medical device company focused solely on cancer

Key Technology Patent Includes Radiofrequency and Microwave Energy Sources for the Purpose of Performing Ablation

Company Achieves Record Quarterly and 2005 Revenues, Positive Cash Flow Generated From Operations, Company Takes a $5.5 Million Impairment Charge

FREMONT, Calif., Feb. 7 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2005, after the market close on Thursday, February 23, 2006.

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jan. 17, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) announced that Peter J. Graham, 39, was named to its board of directors effective January 16, 2006. Mr. Graham fills the seat previously held by Howard S. Stern, who passed away late last year. Mr.

QUEENSBURY, N.Y., Jan 03, 2006 (BUSINESS WIRE) -- AngioDynamics, Inc. (Nasdaq:ANGO) regrets to announce that Howard S. Stern, its co-founder, former chairman of the board of directors, and current director has passed away at the age of 74 after losing his battle with brain cancer. Mr.

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jan. 3, 2006--AngioDynamics, Inc., (Nasdaq:ANGO) announced today that it has filed a complaint in the United States District Court for the District of Delaware against Diomed, Inc. (AMEX:DIO). AngioDynamics is seeking a judgment declaring that the claims of

FREMONT, Calif., Jan. 3 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at the 8th Annual Needham & Company, LLC Growth Conference, which will

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jan. 3, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) regrets to announce that Howard S. Stern, its co-founder, former chairman of the board of directors, and current director has passed away at the age of 74 after losing his battle with brain cancer. Mr.

AngioDynamics Files Summary Judgment Motion of Non-Infringement in Patent Lawsuit with Diomed QUEENSBURY, N.Y., Dec 21, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (Nasdaq:ANGO) today announced the Company has filed a Motion for Summary Judgment of Non-Infringement in the federal district court in

AngioDynamics Net Income Up 60% on 30% Increase to Record Net Sales in Second Quarter of Fiscal 2006; Conference Call to Begin Today at 4:30 pm ET QUEENSBURY, N.Y., Dec 19, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (Nasdaq:ANGO) today announced financial results for the 13 and 26 weeks ended

AngioDynamics Announces Launch of the TOTAL ABSCESSION General Drainage Catheter QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 16, 2005--AngioDynamics, Inc. (NASDAQ:ANGO) today announced the launch of the TOTAL ABSCESSION ® general drainage catheter designed to percutaneously drain abscesses and

AngioDynamics to Hold Fiscal 2006 Second Quarter Financial Results Conference Call on Monday, December 19, 2005 QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 13, 2005--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release fiscal 2006 second quarter results after the market

AngioDynamics to Present at the First Albany Capital Annual Growth Conference on December 7th QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 2, 2005--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that its president and chief executive officer, Eamonn P.

Radiofrequency Ablation Treatment Shown to Improve Survival Rates and Patient Outcomes Across Multiple Organs

FREMONT, Calif.--(BUSINESS WIRE)--Nov. 22, 2005-- Medicare Increases Hospital Outpatient Payment for Liver Cancer Radiofrequency Ablation

RITA Medical Resumes Volume Shipments of HABIB(TM)4X Resection Device FREMONT, Calif., Nov. 15 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it resumed volume shipments of the

AngioDynamics Launches Sotradecol at American College of Phlebology Meeting AngioDynamics Launches Sotradecol at American College of Phlebology Meeting QUEENSBURY, N.Y., Nov 07, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc., (Nasdaq:ANGO) today announced it will launch Sotradecol ™ at the 19th

RITA Medical Systems Reports Third Quarter Results RITA Medical Systems Reports Third Quarter Results FREMONT, Calif., Nov. 1 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today reported financial